Epidemiological Characteristics and Spatio-Temporal Distribution of Hepatitis A in Spain in the Context of the 2016/2017 European Outbreak.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 12 2022
Historique:
received: 08 11 2022
revised: 02 12 2022
accepted: 09 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

The aim of our study was to describe the results of the epidemiological surveillance of hepatitis A infections in Spain in the context of the 2016/2017 European outbreak, particularly of hepatitis A outbreaks reported in the MSM population, incorporating the results of a spatio-temporal analysis of cases. Hepatitis A cases and outbreaks reported in 2016-2017 to the National Epidemiological Surveillance Network were reviewed: outbreaks in which some of the cases belonged to the MSM group were described, and clusters of hepatitis A cases in men and women were analysed using a space-time scan statistic. Twenty-six outbreaks were identified, with a median size of two cases per outbreak, with most of the outbreak-related cases belonging to the 15-44 years-old group. Nearly 85% occurred in a household setting, and in all outbreaks, the mode of transmission was direct person-to-person contact. Regarding space-time analysis, twenty statistically significant clusters were identified in the male population and eight in the female population; clusters in men presented a higher number of observed cases and affected municipalities, as well as a higher percentage of municipalities classified as large urban areas. The elevated number of cases detected in clusters of men indicates that the number of MSM-related outbreaks may be higher than reported, showing that spatio-temporal analysis is a complementary, useful tool which may improve the detection of outbreaks in settings where epidemiological investigation may be more challenging.

Identifiants

pubmed: 36554666
pii: ijerph192416775
doi: 10.3390/ijerph192416775
pmc: PMC9778781
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2015 Apr 16;20(15):
pubmed: 25953129
Euro Surveill. 2017 Feb 23;22(8):
pubmed: 28251892
Rev Esp Salud Publica. 2020 Jan 24;94:
pubmed: 31974339
J Nurs Manag. 2021 Jan;29(1):32-42
pubmed: 33065773
Liver Int. 2018 Apr;38(4):588-593
pubmed: 28980376
Int J Health Geogr. 2013 Mar 16;12:15
pubmed: 23497235
Wkly Epidemiol Rec. 2012 Jul 13;87(28/29):261–76
pubmed: 22905367
Vaccine. 2015 Oct 13;33(42):5723-5727
pubmed: 26190091
Vaccine. 2019 May 9;37(21):2849-2856
pubmed: 30992222
Euro Surveill. 2018 Aug;23(33):
pubmed: 30131095
Int J Health Geogr. 2017 Dec 2;16(1):45
pubmed: 29197383
Int J Health Geogr. 2012 May 29;11:17
pubmed: 22642702
Hum Vaccin Immunother. 2019;15(2):426-432
pubmed: 30431383
Euro Surveill. 2018 Jun;23(23):
pubmed: 29897040
Epidemiol Infect. 2010 Jun;138(6):873-83
pubmed: 19796449
Vaccine X. 2019 Feb 28;1:100014
pubmed: 31384736
BMC Infect Dis. 2012 Jan 20;12:11
pubmed: 22264382
Int J Infect Dis. 2021 Feb;103:146-153
pubmed: 33207272
Acta Biomed. 2020 Apr 10;91(3-S):106-110
pubmed: 32275274
Epidemiol Infect. 2016 May;144(7):1528-37
pubmed: 26566273
J Gen Virol. 2003 Dec;84(Pt 12):3191-3201
pubmed: 14645901
PLoS One. 2017 Nov 10;12(11):e0185428
pubmed: 29125835
Epidemiol Infect. 2013 Nov;141(11):2354-64
pubmed: 23347688
Euro Surveill. 2009 Nov 26;14(47):
pubmed: 19941803

Auteurs

María Guerrero-Vadillo (M)

Doctorate Programme in Biomedical Sciences and Public Health, National University of Distance Education (UNED), 28015 Madrid, Spain.
National Centre for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Marina Peñuelas (M)

National Centre for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Ángela Domínguez (Á)

Departament de Medicina, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Pere Godoy (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Department of Medicine, Institut de Recerca Biomédica de Lleida (IRBLLeida)-Universidad de Lleida, 25008 Lleida, Spain.

Diana Gómez-Barroso (D)

National Centre for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Nuria Soldevila (N)

Departament de Medicina, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Conchita Izquierdo (C)

Agència de Salut Pública de Catalunya, 08005 Barcelona, Spain.

Ana Martínez (A)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Agència de Salut Pública de Catalunya, 08005 Barcelona, Spain.

Nuria Torner (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Ana Avellón (A)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Hepatitis Unit, National Centre of Microbiology, Instituto de Salud Carlos III, 28222 Majadahonda, Spain.

Cristina Rius (C)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
Agència de Salut Pública de Barcelona, 08023 Barcelona, Spain.

Carmen Varela (C)

National Centre for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH